Read more

March 13, 2023
1 min read
Save

NKF presents Donald W. Seldin Award to Melanie P. Hoenig, MD

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

The National Kidney Foundation has named Melanie P. Hoenig, MD, a Harvard Medical School educator and nephrologist, the 2023 winner of the Donald W. Seldin Award, according to a press release.

The award was established to recognize excellence and dedication in nephrology research and education. NKF will honor Hoenig during this year’s NKFs Spring Clinical Meetings, scheduled to be held April 11-15, in Austin, Texas.

Melanie P. Hoenig

“Dr. Hoenig has not only dedicated her career to educating the next generation of nephrologists but has worked to inspire undergraduate and medical students to come into the field,” Sylvia E. Rosas, MD, MSCE, NKF president, said in the release. “She has been the course director for renal pathophysiology at Harvard Medical School for more than a decade. Her commitment to education will only help the patients in the future, with more experts, research and treatments, and ultimately, cures.”

The award is named after Seldin, who died in 2018, and was established to recognize excellence in the tradition of one of the foremost teachers and researchers in the specialty, according to the release. Seldin was widely known as the intellectual father of the University of Texas Southwestern Medical Center.

“As a young trainee, I once heard Dr. Seldin speak and knew that I was in the presence of a remarkable physiologist and educator,” Hoenig said. “I could never imagine that I would someday win an award with his name. This is a true honor.”

Hoenig is an associate professor of medicine at Beth Israel Deaconess Medical Center and associate professor at Harvard Medical School. She recently served as chair of the American Association of Clinical Chemistry’s eGFR and Race Equity Task Force, which endorsed new eGFR formulas to estimate kidney function without race. Her clinical interests are kidney disease in the context of HIV and the transition to adult care for young people with kidney disease.